19828532

Source:http://linkedlifedata.com/resource/pubmed/id/19828532

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019693, umls-concept:C0021756, umls-concept:C0030705, umls-concept:C0087111
pubmed:issue	16
pubmed:dateCreated	2009-10-15
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00004978, http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00013611
pubmed:abstractText	Used in combination with antiretroviral therapy, subcutaneous recombinant interleukin-2 raises CD4+ cell counts more than does antiretroviral therapy alone. The clinical implication of these increases is not known.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/U01 AI068641, http://linkedlifedata.com/resource/pubmed/grant/U01 AI46957
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19828532-20089981, http://linkedlifedata.com/resource/pubmed/commentcorrection/19828532-20425051
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Retroviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/aldesleukin
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1533-4406
pubmed:author	pubmed-author:AbramsDD, pubmed-author:BabikerAA, pubmed-author:CollinsGG, pubmed-author:CooperD ADA, pubmed-author:DarbyshireJJ, pubmed-author:EmerySS, pubmed-author:FoxLL, pubmed-author:GordinFF, pubmed-author:INSIGHT-ESPRIT Study Group, pubmed-author:LévyYY, pubmed-author:LaneH CHC, pubmed-author:LossoM HMH, pubmed-author:LundgrenJ DJD, pubmed-author:MitsuyasuRR, pubmed-author:NeatonJ DJD, pubmed-author:PhillipsAA, pubmed-author:RoutyJ PJP, pubmed-author:SILCAAT Scientific Committee, pubmed-author:TambussiGG, pubmed-author:WentworthDD
pubmed:copyrightInfo	2009 Massachusetts Medical Society
pubmed:issnType	Electronic
pubmed:day	15
pubmed:volume	361
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1548-59
pubmed:dateRevised	2010-4-28
pubmed:meshHeading	pubmed-meshheading:19828532-AIDS-Related Opportunistic Infections, pubmed-meshheading:19828532-Adult, pubmed-meshheading:19828532-Anti-Retroviral Agents, pubmed-meshheading:19828532-Antiretroviral Therapy, Highly Active, pubmed-meshheading:19828532-CD4 Lymphocyte Count, pubmed-meshheading:19828532-Drug Therapy, Combination, pubmed-meshheading:19828532-Female, pubmed-meshheading:19828532-Follow-Up Studies, pubmed-meshheading:19828532-HIV, pubmed-meshheading:19828532-HIV Infections, pubmed-meshheading:19828532-Humans, pubmed-meshheading:19828532-Injections, Subcutaneous, pubmed-meshheading:19828532-Interleukin-2, pubmed-meshheading:19828532-Male, pubmed-meshheading:19828532-RNA, Viral, pubmed-meshheading:19828532-Recombinant Proteins
pubmed:year	2009
pubmed:articleTitle	Interleukin-2 therapy in patients with HIV infection.
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural